Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharmaceutical stocks.
Rakesh Bansal, Vice President at RK Global buying Apollo Hospitals Enterprises and Biocon.
Sudarshan Sukhani of s2analytics.com advises selling Just Dial and buying Hindustan Unilever.
VK Sharma of HDFC Securities is of the view that one can buy Apollo Hospitals 1400 Call and Wockhardt 1650 Call.
Aditya Agarwal of Way2Wealth Securities is of the view that one may sell State Bank of India with a target of Rs 222-220.
Sameet Chavan of Angel Broking recommends selling Lupin and advises buying Apollo Hospitals.
Watch the interview of Prakash Gaba of prakashgaba.com with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on the market, specific stocks and sectors.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Apollo Hospital Enterprises.
Rahul Mohindar of viratechindia.com likes Cipla with a target of Rs 670-675.
Sudarshan Sukhani of s2analytics.com is of the view that one can go long in pharma stocks.
Manoj Murlidharan of Religare Securities is of the view that one can buy Apollo Hospitals with a target of Rs 1420.
Gaurav Bissa of LKP Securities advises selling Tata Motors with a target of Rs 395.
Ashish Kyal of wavesstrategy.com is of the view that one may sell Bosch with a target of Rs 17800.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Apollo Hospital, Sun TV and Ashok Leyland.
Sudarshan Sukhani of s2analytics.com advises buying Ashok Leyland, Apollo Hospitals Enterprises and Sun TV Network.
Rajat Bose of rajatkbose.com feels that Apollo Hospital Enterprises may test Rs 1335-1348.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may buy Larsen and Toubro (L&T) with a target of Rs 1435.
Vishal Malkan of malkansview.com is of the view that one may buy Voltas with a target of Rs 278.
Rahul Mohindar of viratechindia.com recommends buying ITC for a target of Rs 355-360.
Manav Chopra of Monarch Networth Capital suggests buying Apollo Hospitals Enterprises with a target of Rs 1420.
Ashish Kyal of wavesstrategy.com suggests buying Jubilant Life Sciences with a target of Rs 470.
Amit Gupta of ICICIdirect is of the view that Apollo Hospitals may test Rs 1,580.
Manav Chopra of Networth Stock Broking advises buying Tata Motors with a target of Rs 360.
Amit Gupta of ICICIdirect recommends buying Apollo Hospitals on dips of Rs 20-30 and expects a target of Rs 1,560.
Gaurav Bissa of LKP Securities is of the view that Apollo Hospitals may head towards Rs 1550.